Dow Up 1.09% Nasdaq Up 2.19%

Pharmacyclics Inc. (PCYC)

-NasdaqGS
115.94 1.11(0.97%)
Prev Close:114.83
Open:N/A
Bid:115.86 x 100
Ask:116.03 x 100
1y Target Est:157.39
Beta:1.09
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:114.09 - 117.00
52wk Range:82.51 - 154.89
Volume:N/A
Avg Vol (3m):924,142
Market Cap:N/A
P/E (ttm):0.00
EPS (ttm):1.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PCYC

Comparison

Symbol% ChgMkt Cap
PCYCUp 0.97%N/A
CTICN/A
MRKN/A

Key Statistics

Forward P/E (1 yr):11,594.00
P/S (ttm):19.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.31
Quarterly EPS Est (Sep-14) :0.38
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2,315.13

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pharmacyclics, Inc., a biopharmaceutical company, designs, develops, and commercializes small-molecule drugs for the treatment of cancer and immune mediated diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback